| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 14 | 2015 | 32 | 4.260 |
Why?
|
| Pre-Eclampsia | 11 | 2022 | 57 | 3.650 |
Why?
|
| Streptococcus pyogenes | 14 | 2009 | 25 | 3.510 |
Why?
|
| Texas | 31 | 2023 | 299 | 2.900 |
Why?
|
| Anaphylaxis | 7 | 2012 | 14 | 2.580 |
Why?
|
| Length of Stay | 17 | 2016 | 184 | 2.460 |
Why?
|
| Fasciitis, Necrotizing | 9 | 2008 | 11 | 2.180 |
Why?
|
| Retrospective Studies | 32 | 2021 | 1961 | 1.720 |
Why?
|
| Faculty | 3 | 2020 | 82 | 1.690 |
Why?
|
| Hospital Mortality | 11 | 2015 | 183 | 1.530 |
Why?
|
| Pregnancy | 22 | 2023 | 1503 | 1.470 |
Why?
|
| Humans | 92 | 2023 | 34853 | 1.460 |
Why?
|
| Eclampsia | 4 | 2011 | 10 | 1.440 |
Why?
|
| Hospitalization | 11 | 2021 | 370 | 1.360 |
Why?
|
| Female | 65 | 2023 | 19873 | 1.320 |
Why?
|
| Florida | 18 | 2012 | 358 | 1.260 |
Why?
|
| Risk Factors | 24 | 2018 | 3414 | 1.130 |
Why?
|
| Adult | 42 | 2020 | 11034 | 1.110 |
Why?
|
| Regression Analysis | 4 | 2020 | 429 | 1.100 |
Why?
|
| Maternal Age | 4 | 2018 | 27 | 1.100 |
Why?
|
| Odds Ratio | 18 | 2018 | 517 | 1.100 |
Why?
|
| Patient Discharge | 7 | 2023 | 92 | 1.070 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2021 | 248 | 1.030 |
Why?
|
| Patient Admission | 4 | 2012 | 40 | 1.020 |
Why?
|
| Health Care Costs | 2 | 2020 | 69 | 1.010 |
Why?
|
| Streptococcus agalactiae | 2 | 2015 | 10 | 0.970 |
Why?
|
| Colposcopy | 2 | 2021 | 13 | 0.970 |
Why?
|
| Mexican Americans | 3 | 2017 | 177 | 0.950 |
Why?
|
| Adolescent | 22 | 2020 | 5035 | 0.900 |
Why?
|
| Pain | 2 | 2020 | 249 | 0.870 |
Why?
|
| Prevalence | 14 | 2015 | 1425 | 0.850 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 132 | 0.850 |
Why?
|
| Middle Aged | 33 | 2020 | 9642 | 0.840 |
Why?
|
| Population Surveillance | 5 | 2011 | 231 | 0.820 |
Why?
|
| Seasons | 3 | 2011 | 112 | 0.810 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2021 | 23 | 0.800 |
Why?
|
| Aged | 26 | 2021 | 6448 | 0.780 |
Why?
|
| Mass Casualty Incidents | 1 | 2020 | 2 | 0.780 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 99 | 0.780 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 41 | 0.780 |
Why?
|
| Education, Professional | 1 | 2020 | 5 | 0.770 |
Why?
|
| Poisson Distribution | 1 | 2020 | 39 | 0.760 |
Why?
|
| Eye Injuries | 1 | 2020 | 2 | 0.760 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 26 | 0.760 |
Why?
|
| Staff Development | 1 | 2020 | 28 | 0.760 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 27 | 0.750 |
Why?
|
| Faculty, Medical | 1 | 2020 | 63 | 0.750 |
Why?
|
| Adenocarcinoma | 3 | 2015 | 239 | 0.730 |
Why?
|
| Resilience, Psychological | 1 | 2020 | 61 | 0.720 |
Why?
|
| Pain Measurement | 1 | 2020 | 161 | 0.710 |
Why?
|
| Young Adult | 14 | 2020 | 4012 | 0.700 |
Why?
|
| Anti-Bacterial Agents | 9 | 2011 | 355 | 0.690 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 63 | 0.680 |
Why?
|
| Paternal Age | 1 | 2018 | 2 | 0.680 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 70 | 0.680 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 10 | 0.680 |
Why?
|
| Internet | 1 | 2020 | 204 | 0.670 |
Why?
|
| Eye Diseases | 2 | 2012 | 23 | 0.660 |
Why?
|
| Sterilization, Reproductive | 1 | 2018 | 2 | 0.660 |
Why?
|
| Schools, Medical | 1 | 2020 | 192 | 0.650 |
Why?
|
| Curriculum | 1 | 2020 | 237 | 0.650 |
Why?
|
| Child, Preschool | 12 | 2018 | 1318 | 0.640 |
Why?
|
| Stomach Neoplasms | 2 | 2012 | 192 | 0.630 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 15 | 0.620 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 303 | 0.610 |
Why?
|
| Infant | 9 | 2022 | 1014 | 0.610 |
Why?
|
| Child | 14 | 2018 | 2875 | 0.610 |
Why?
|
| Male | 34 | 2020 | 18870 | 0.610 |
Why?
|
| Mexico | 5 | 2023 | 223 | 0.600 |
Why?
|
| Pregnancy Outcome | 2 | 2018 | 90 | 0.590 |
Why?
|
| Age Factors | 9 | 2020 | 1007 | 0.580 |
Why?
|
| Smoking | 1 | 2023 | 903 | 0.570 |
Why?
|
| Appendicitis | 1 | 2016 | 18 | 0.570 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 2333 | 0.540 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2015 | 6 | 0.530 |
Why?
|
| Case-Control Studies | 7 | 2017 | 1056 | 0.520 |
Why?
|
| Health Promotion | 1 | 2020 | 588 | 0.510 |
Why?
|
| Incidence | 7 | 2020 | 882 | 0.500 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 790 | 0.500 |
Why?
|
| Hypotension | 2 | 2005 | 21 | 0.500 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 112 | 0.490 |
Why?
|
| Registries | 3 | 2020 | 330 | 0.480 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 375 | 0.460 |
Why?
|
| Emergency Service, Hospital | 2 | 2012 | 188 | 0.460 |
Why?
|
| Infant, Newborn | 7 | 2022 | 871 | 0.460 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 6 | 0.450 |
Why?
|
| Clindamycin | 4 | 2007 | 12 | 0.450 |
Why?
|
| Obstetrics | 4 | 2019 | 38 | 0.450 |
Why?
|
| Insurance Coverage | 2 | 2020 | 99 | 0.450 |
Why?
|
| Hyponatremia | 1 | 2012 | 6 | 0.450 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2012 | 2 | 0.440 |
Why?
|
| Insulin Infusion Systems | 1 | 2012 | 3 | 0.440 |
Why?
|
| United States | 12 | 2018 | 3894 | 0.440 |
Why?
|
| Accidental Falls | 1 | 2012 | 26 | 0.440 |
Why?
|
| Hypoglycemia | 1 | 2012 | 17 | 0.440 |
Why?
|
| Hip Fractures | 1 | 2012 | 26 | 0.440 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 221 | 0.430 |
Why?
|
| Carcinosarcoma | 1 | 2012 | 4 | 0.430 |
Why?
|
| Serum Albumin | 2 | 2009 | 49 | 0.430 |
Why?
|
| Hospital Charges | 1 | 2012 | 13 | 0.430 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 20 | 0.420 |
Why?
|
| Logistic Models | 7 | 2016 | 894 | 0.410 |
Why?
|
| Peanut Hypersensitivity | 1 | 2011 | 1 | 0.410 |
Why?
|
| Death Certificates | 1 | 2011 | 12 | 0.400 |
Why?
|
| Postoperative Complications | 1 | 2012 | 206 | 0.390 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 152 | 0.390 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2010 | 20 | 0.380 |
Why?
|
| Insulin | 1 | 2012 | 224 | 0.380 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 5 | 0.380 |
Why?
|
| Hospitals, State | 1 | 2010 | 2 | 0.370 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2010 | 4 | 0.370 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 6 | 0.370 |
Why?
|
| Glucose Tolerance Test | 1 | 2010 | 66 | 0.370 |
Why?
|
| Melanoma | 2 | 2009 | 91 | 0.370 |
Why?
|
| Models, Statistical | 2 | 2011 | 171 | 0.360 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 628 | 0.360 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2009 | 2 | 0.350 |
Why?
|
| Placental Insufficiency | 1 | 2009 | 2 | 0.350 |
Why?
|
| Gestational Age | 3 | 2023 | 190 | 0.350 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2008 | 33 | 0.350 |
Why?
|
| Uveal Neoplasms | 1 | 2009 | 8 | 0.350 |
Why?
|
| Parturition | 1 | 2009 | 22 | 0.350 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 51 | 0.350 |
Why?
|
| Comorbidity | 6 | 2020 | 606 | 0.350 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 111 | 0.350 |
Why?
|
| Primary Health Care | 1 | 2012 | 283 | 0.340 |
Why?
|
| Postpartum Period | 1 | 2008 | 59 | 0.330 |
Why?
|
| Gynecology | 4 | 2019 | 31 | 0.330 |
Why?
|
| Helicobacter Infections | 4 | 2011 | 74 | 0.330 |
Why?
|
| Insect Bites and Stings | 1 | 2007 | 2 | 0.320 |
Why?
|
| International Classification of Diseases | 3 | 2015 | 18 | 0.320 |
Why?
|
| Helicobacter pylori | 4 | 2011 | 105 | 0.320 |
Why?
|
| Purpura | 1 | 2007 | 3 | 0.320 |
Why?
|
| Ophthalmology | 2 | 2012 | 28 | 0.320 |
Why?
|
| Kidney Diseases | 1 | 2010 | 159 | 0.320 |
Why?
|
| Cellulitis | 1 | 2007 | 7 | 0.320 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 28 | 0.310 |
Why?
|
| Emergency Medicine | 2 | 2010 | 23 | 0.290 |
Why?
|
| Coccidioidomycosis | 1 | 2007 | 46 | 0.290 |
Why?
|
| Asthma | 1 | 2010 | 363 | 0.280 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2005 | 2 | 0.280 |
Why?
|
| Ultrasonography | 3 | 2019 | 115 | 0.280 |
Why?
|
| Accidents, Home | 1 | 2005 | 7 | 0.280 |
Why?
|
| Malpractice | 1 | 2005 | 2 | 0.270 |
Why?
|
| Immunogenetics | 1 | 2005 | 2 | 0.260 |
Why?
|
| Nursing Homes | 1 | 2005 | 41 | 0.260 |
Why?
|
| Hospitals, Religious | 1 | 2004 | 1 | 0.260 |
Why?
|
| Critical Pathways | 1 | 2004 | 15 | 0.260 |
Why?
|
| Cohort Studies | 3 | 2018 | 1422 | 0.260 |
Why?
|
| Ovariectomy | 2 | 2018 | 104 | 0.260 |
Why?
|
| Obesity | 3 | 2010 | 965 | 0.260 |
Why?
|
| Cesarean Section | 2 | 2018 | 53 | 0.250 |
Why?
|
| Community-Acquired Infections | 1 | 2004 | 24 | 0.250 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 964 | 0.250 |
Why?
|
| Diabetes Complications | 4 | 2009 | 91 | 0.250 |
Why?
|
| Pneumonia | 1 | 2004 | 50 | 0.240 |
Why?
|
| Bromhexine | 1 | 2023 | 2 | 0.240 |
Why?
|
| Salmonella Infections | 1 | 2004 | 16 | 0.240 |
Why?
|
| Internship and Residency | 2 | 2019 | 121 | 0.240 |
Why?
|
| Vaginal Smears | 2 | 2021 | 52 | 0.240 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 155 | 0.240 |
Why?
|
| Peritonitis | 1 | 2003 | 8 | 0.230 |
Why?
|
| Schools | 1 | 2005 | 229 | 0.230 |
Why?
|
| Liver | 2 | 2016 | 447 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2012 | 2561 | 0.230 |
Why?
|
| Birth Weight | 1 | 2023 | 93 | 0.220 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 39 | 0.220 |
Why?
|
| Risk Assessment | 4 | 2018 | 727 | 0.210 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 14 | 0.200 |
Why?
|
| Curettage | 1 | 2020 | 3 | 0.190 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 54 | 0.190 |
Why?
|
| Writing | 1 | 2020 | 33 | 0.190 |
Why?
|
| Microscopy | 1 | 2020 | 32 | 0.190 |
Why?
|
| Medically Underserved Area | 1 | 2020 | 98 | 0.180 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2020 | 38 | 0.180 |
Why?
|
| Confidence Intervals | 2 | 2010 | 151 | 0.180 |
Why?
|
| Leadership | 1 | 2020 | 63 | 0.180 |
Why?
|
| Medicaid | 2 | 2012 | 102 | 0.180 |
Why?
|
| Survival Rate | 4 | 2015 | 310 | 0.180 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 34 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 608 | 0.170 |
Why?
|
| Comprehension | 1 | 2019 | 30 | 0.170 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 48 | 0.170 |
Why?
|
| Torsion Abnormality | 1 | 2018 | 3 | 0.170 |
Why?
|
| Ovarian Diseases | 1 | 2018 | 3 | 0.170 |
Why?
|
| Women's Health Services | 1 | 2018 | 10 | 0.160 |
Why?
|
| Intensive Care Units | 2 | 2012 | 57 | 0.160 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 24 | 0.160 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 38 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2019 | 124 | 0.160 |
Why?
|
| Ovulation Induction | 1 | 2017 | 6 | 0.160 |
Why?
|
| Fertility Agents, Female | 1 | 2017 | 6 | 0.160 |
Why?
|
| Gonadotropins | 1 | 2017 | 21 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2007 | 17 | 0.160 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2017 | 41 | 0.160 |
Why?
|
| Ovarian Follicle | 1 | 2017 | 31 | 0.160 |
Why?
|
| Bayes Theorem | 2 | 2022 | 91 | 0.150 |
Why?
|
| Language | 1 | 2019 | 143 | 0.150 |
Why?
|
| Nitriles | 1 | 2017 | 66 | 0.150 |
Why?
|
| Premature Birth | 1 | 2018 | 71 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 207 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 531 | 0.150 |
Why?
|
| Triazoles | 1 | 2017 | 85 | 0.150 |
Why?
|
| Iron Overload | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cholangitis | 1 | 2016 | 1 | 0.140 |
Why?
|
| Gene Products, env | 1 | 2016 | 23 | 0.140 |
Why?
|
| CD4-CD8 Ratio | 1 | 2016 | 28 | 0.140 |
Why?
|
| Jaundice | 1 | 2016 | 7 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2016 | 16 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2010 | 288 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2023 | 1349 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2016 | 24 | 0.140 |
Why?
|
| Ligaments | 1 | 2015 | 2 | 0.140 |
Why?
|
| Endoscopy | 1 | 2015 | 15 | 0.140 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2015 | 5 | 0.140 |
Why?
|
| Hysterectomy | 1 | 2015 | 29 | 0.140 |
Why?
|
| Ureteral Obstruction | 1 | 2015 | 17 | 0.130 |
Why?
|
| Health Personnel | 1 | 2017 | 200 | 0.130 |
Why?
|
| Cacao | 1 | 2015 | 10 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2015 | 54 | 0.130 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 46 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2016 | 119 | 0.130 |
Why?
|
| Iron, Dietary | 2 | 2011 | 13 | 0.130 |
Why?
|
| Adenoma | 1 | 2015 | 89 | 0.130 |
Why?
|
| Heart Failure | 2 | 2007 | 230 | 0.130 |
Why?
|
| Iron | 1 | 2016 | 204 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 213 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 84 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1426 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 251 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 176 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 231 | 0.120 |
Why?
|
| Breech Presentation | 1 | 2012 | 4 | 0.110 |
Why?
|
| Twins | 1 | 2012 | 16 | 0.110 |
Why?
|
| Ferritins | 2 | 2011 | 54 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2012 | 19 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 37 | 0.110 |
Why?
|
| Nursing Care | 1 | 2012 | 6 | 0.110 |
Why?
|
| Time Factors | 1 | 2017 | 1681 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2012 | 57 | 0.110 |
Why?
|
| Physicians, Family | 1 | 2012 | 19 | 0.110 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 51 | 0.110 |
Why?
|
| Yolk Sac | 1 | 2012 | 4 | 0.110 |
Why?
|
| Sodium | 1 | 2012 | 101 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2012 | 128 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2012 | 10 | 0.110 |
Why?
|
| Risk | 1 | 2012 | 256 | 0.100 |
Why?
|
| Pediatrics | 1 | 2012 | 66 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2012 | 53 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 56 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 37 | 0.100 |
Why?
|
| Health Services Research | 1 | 2012 | 133 | 0.100 |
Why?
|
| New York | 1 | 2011 | 69 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2012 | 213 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2012 | 105 | 0.100 |
Why?
|
| Geography | 1 | 2011 | 86 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 211 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2012 | 420 | 0.090 |
Why?
|
| Burnout, Professional | 1 | 2010 | 17 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 186 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 188 | 0.090 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2011 | 20 | 0.090 |
Why?
|
| Cephalosporins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Penicillins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Fasting | 1 | 2010 | 50 | 0.090 |
Why?
|
| Multilingualism | 1 | 2010 | 31 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 42 | 0.090 |
Why?
|
| Markov Chains | 1 | 2009 | 32 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 55 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 583 | 0.090 |
Why?
|
| Medically Uninsured | 1 | 2009 | 49 | 0.090 |
Why?
|
| Minnesota | 1 | 2009 | 39 | 0.090 |
Why?
|
| Culture | 1 | 2010 | 162 | 0.090 |
Why?
|
| Paternity | 1 | 2008 | 1 | 0.090 |
Why?
|
| Birth Intervals | 1 | 2008 | 3 | 0.090 |
Why?
|
| Endometrial Hyperplasia | 1 | 2008 | 3 | 0.090 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 217 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 106 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 223 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2009 | 212 | 0.080 |
Why?
|
| Recurrence | 1 | 2008 | 125 | 0.080 |
Why?
|
| Linear Models | 1 | 2009 | 253 | 0.080 |
Why?
|
| HIV Infections | 2 | 2016 | 2207 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2006 | 18 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2010 | 333 | 0.080 |
Why?
|
| Natriuretic Agents | 1 | 2007 | 3 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 20 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 424 | 0.080 |
Why?
|
| Endometrium | 1 | 2008 | 57 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2008 | 64 | 0.080 |
Why?
|
| Reproductive Medicine | 1 | 2007 | 5 | 0.080 |
Why?
|
| Population | 1 | 2007 | 7 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 34 | 0.080 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2007 | 16 | 0.080 |
Why?
|
| Canada | 1 | 2007 | 121 | 0.080 |
Why?
|
| Heating | 1 | 2005 | 4 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2007 | 322 | 0.070 |
Why?
|
| Consumer Product Safety | 1 | 2005 | 10 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 18 | 0.070 |
Why?
|
| Cold Temperature | 1 | 2005 | 39 | 0.070 |
Why?
|
| Space-Time Clustering | 1 | 2005 | 3 | 0.070 |
Why?
|
| Multi-Institutional Systems | 1 | 2004 | 1 | 0.070 |
Why?
|
| Protein C | 1 | 2004 | 2 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 707 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 92 | 0.060 |
Why?
|
| Orbital Diseases | 1 | 2004 | 1 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 55 | 0.060 |
Why?
|
| Health Services Administration | 1 | 2004 | 5 | 0.060 |
Why?
|
| Eyelid Diseases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Government Agencies | 1 | 2004 | 9 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2004 | 82 | 0.060 |
Why?
|
| Patient Transfer | 1 | 2004 | 22 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2004 | 22 | 0.060 |
Why?
|
| Ofloxacin | 1 | 2003 | 6 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 901 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 62 | 0.060 |
Why?
|
| Conjunctival Neoplasms | 1 | 2002 | 1 | 0.060 |
Why?
|
| Observer Variation | 1 | 2002 | 57 | 0.050 |
Why?
|
| California | 1 | 2004 | 436 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2007 | 371 | 0.050 |
Why?
|
| ROC Curve | 1 | 2002 | 138 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2002 | 121 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2002 | 110 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1003 | 0.050 |
Why?
|
| Intention to Treat Analysis | 2 | 2011 | 11 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 325 | 0.050 |
Why?
|
| Mass Screening | 1 | 2005 | 427 | 0.050 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 1 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 4 | 0.050 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 19 | 0.050 |
Why?
|
| Disease Progression | 1 | 2003 | 580 | 0.050 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2020 | 18 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 29 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 37 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2011 | 269 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2022 | 347 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 204 | 0.040 |
Why?
|
| Glycemic Index | 1 | 2019 | 8 | 0.040 |
Why?
|
| Dietary Supplements | 2 | 2011 | 196 | 0.040 |
Why?
|
| Rural Population | 1 | 2020 | 253 | 0.040 |
Why?
|
| Pamphlets | 1 | 2019 | 27 | 0.040 |
Why?
|
| Pregnancy, Multiple | 1 | 2018 | 6 | 0.040 |
Why?
|
| Stillbirth | 1 | 2018 | 7 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 53 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2018 | 17 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 316 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 555 | 0.040 |
Why?
|
| Poverty | 1 | 2020 | 316 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 2017 | 14 | 0.040 |
Why?
|
| Ovulation | 1 | 2017 | 20 | 0.040 |
Why?
|
| Infertility, Female | 1 | 2017 | 24 | 0.040 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2017 | 26 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 859 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 292 | 0.040 |
Why?
|
| Health Literacy | 1 | 2019 | 100 | 0.040 |
Why?
|
| Endometriosis | 1 | 2017 | 69 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 6 | 0.040 |
Why?
|
| Cystoscopy | 1 | 2015 | 4 | 0.030 |
Why?
|
| Stents | 1 | 2016 | 59 | 0.030 |
Why?
|
| SEER Program | 1 | 2015 | 87 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 423 | 0.030 |
Why?
|
| Myocardium | 1 | 2016 | 224 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 650 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 468 | 0.030 |
Why?
|
| Abortion, Missed | 1 | 2012 | 1 | 0.030 |
Why?
|
| Monosomy | 1 | 2012 | 1 | 0.030 |
Why?
|
| Turner Syndrome | 1 | 2012 | 2 | 0.030 |
Why?
|
| Trisomy | 1 | 2012 | 10 | 0.030 |
Why?
|
| Karyotyping | 1 | 2012 | 46 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 33 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 1353 | 0.030 |
Why?
|
| Species Specificity | 1 | 2011 | 233 | 0.020 |
Why?
|
| General Surgery | 1 | 2010 | 20 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 38 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2010 | 25 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 358 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 24 | 0.020 |
Why?
|
| HIV-1 | 1 | 2016 | 678 | 0.020 |
Why?
|
| Cities | 1 | 2010 | 61 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 13 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2009 | 6 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 628 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1317 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 125 | 0.020 |
Why?
|
| Drug Costs | 1 | 2007 | 28 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 36 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2006 | 113 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2005 | 228 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 642 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 770 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 14307 | 0.010 |
Why?
|